Clay Siegall, Ph.D.: Seattle Genetics Mounting to Great Profit or Quest for Acquisition

It was reported in July 2017 about Seattle Genetics turning from a pharmacy to a big market leader. Seattle Genetics is a dominant biotech organization in the region, but the question is whether Seattle Genetics will be acquisition target or a growth magnet of the local industry.

Seattle Genetics main focus has been the mainly studying about human antibodies. Since being found in 1998, the organization has been manipulating, studying, and packaging drugs. Their strategy could lead them to the big leagues, or they could be like the acquisition of Immunex in Seattle.

So far, their stats include them being worth approximately $10 billion and 900 employees. Thus, they are already ranking as the biggest biotech in Washington. And they heavily invest in marketing and research. They are also planning on adding 200 more personnel to their firm.

The firm also has some drugs that have had moderate to great success so far. Their flagship drug is Adcetris which treats Hodgkin lymphoma which is a lymph system’s cancer. Also, Dr. Clay Siegall stated a bid to spend $2 billion in February to acquire the global rights in commercializing a cancer drug produced by Immunomedics, company based in New Jersey. They are also focusing on an antibody-drug conjugate (ADC) which are drugs that target antigens. Antigens are protein molecules causing the production of antibodies in the immune system. The other drugs they are mainly focusing on include the 22ME which targets the bladder and other urothelial cancers and the LIV1 which targets breast cancer. They have a total of 11 drugs at Seattle Genetics, but these four have the potential of huge immediate sales.

About Clay Siegall

Clay Seigall, Ph.D., is the President, founder, Chairman, and CEO of Seattle Genetics,, which is located in Washington. He co-founded this firm in 1998. This firm has created a grand array of cancer therapies that are based on antibodies. Their drug, Adcetris, was granted a swift approval in 2011 by the US Food and Drug Administration (FDA).

Dr. Siegall’s other experience includes the following: Director, Board of Directors of

Ultragenyx Pharmaceutical since 2014, Director, Board of Directors of Mirna Therapeutics, Inc. since 2013, and the Director, Board of Directors of Alder Biopharmaceuticals Inc. since 2006. He also earned his Ph.D. from the George Washington University in Genetics and a BS degree from the University of Maryland in Zoology.

Categories: CEO

Jose Henrique Borghi; a Big Name in Brazil Advertising Industry

Jose Henrique Borghi is one of the most talented people in the advertising industry. Jose Borghi; the co-CEO of Mullen Lowe advertising agency, uses great unconventional ideas in creating his ads and makes sure his clients are impressed and satisfied. He has an advertisement degree from Pontifical Catholic University, thus has what it takes to make great adverts for effective marketing.

Jose Borghi has helped Mullen Lowe Brasil advertising agency a great deal in developing great advertising campaigns that have led to its success. Mullen Lowe is one of the most major advertising agency in Brazil, and for them to grow in this competitive industry, they had to collaborate with Jose Borghi as his experience speaks loud of himself. At Mullen Lowe, Jose is helpful in social media, design planning, mobile marketing, and public relations. This ensures clients are fully satisfied, and the agency gets more customers each day.

Jose Henrique has created many ads which are very popular in the advertising industry. A good example is a wildlife conservation ad; Mammals of Parmalat, which is a very inspiring ad ever developed in Brazil. He has also created a YouTube skip ad which has a message against women assault. Many of his ads have made him famous and receive many awards nationally and internationally.

Jose Henrique has worked with many businesses and companies. He has created ad campaigns for Unilever, LG, Toyota, Mitsubishi, and fiat. As a marketing strategy, advertisement informs people about a product and encourages people to buy the product. Therefore, great ads created by Jose helps his clients in making more sales and inform people on different brands. His advertising campaigns are designed properly and have a positive impact on businesses.

Jose Borghi uses a unique approach to creating advertising campaigns. It is evident that his contribution in Brazilian advertisement industry is immense. Jose has made Mullen Lowe advertising agency great, and the company has dominated the Brazilian advertising industry.